Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance and predict a poor prognosis in MCL patients independent of CCND1

Osteoblastic niche supports the growth of quiescent multiple myeloma cells

(2014) Z. Chen et al.   BLOOD

Identification of Pax5 Target Genes in Early B Cell Differentiation

(2014) C. Pridans et al.   JOURNAL OF IMMUNOLOGY

Sorafenib Inhibits Lymphoma Xenografts by Targeting MAPK/ERK and AKT Pathways in Tumor and Vascular Cells

(2013) Carmelo Carlo-Stella et al.   PLoS One

STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor

(2013) Y. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management

(2012) Julie M. Vose   AMERICAN JOURNAL OF HEMATOLOGY

Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells

(2012) L. Zhang et al.   BLOOD

PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas

(2012) Daniela Laimer et al.   NATURE MEDICINE

8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma

(2010) J. B. Dennison et al.   BLOOD

Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation

(2010) P. Perez-Galan et al.   BLOOD

Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content

(2010) Salvatore Pece et al.   CELL

Ras Puts the Brake on Doxorubicin-mediated Cell Death in p53-expressing Cells

(2010) Sunil K. Manna et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Phosphatidylinositol 3'-Kinase Catalytic Subunit   Gene Amplification Contributes to the Pathogenesis of Mantle Cell Lymphoma

(2009) A. Psyrri et al.   CLINICAL CANCER RESEARCH

JNK is constitutively active in mantle cell lymphoma: cell cycle deregulation and polyploidy by JNK inhibitor SP600125

(2009) Miao Wang et al.   JOURNAL OF PATHOLOGY

Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma

(2009) E Drakos et al.   LEUKEMIA

Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma

(2008) J. Dal Col et al.   BLOOD

Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas

(2008) M Colomiere et al.   BRITISH JOURNAL OF CANCER

Bortezomib in mantle cell lymphoma

(2008) K Stephen Suh et al.   Future Oncology

Comprehensive Dissection of PDGF-PDGFR Signaling Pathways in PDGFR Genetically Defined Cells

(2008) Erxi Wu et al.   PLoS One